NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88 | -2.2% | 12,100 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $90 | -25.0% | 12,100 | -30.0% | 0.00% | 0.0% |
| Q1 2023 | $120 | -33.7% | 17,293 | -2.0% | 0.00% | -50.0% |
| Q4 2022 | $181 | -99.9% | 17,643 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $321,000 | -64.2% | 17,643 | +1.1% | 0.00% | -62.5% |
| Q2 2022 | $897,000 | -30.6% | 17,443 | -0.6% | 0.01% | -20.0% |
| Q1 2022 | $1,292,000 | -71.7% | 17,546 | -45.1% | 0.01% | -41.2% |
| Q4 2021 | $4,572,000 | +51.9% | 31,960 | +120.1% | 0.02% | -32.0% |
| Q3 2021 | $3,010,000 | -7.6% | 14,521 | -5.3% | 0.02% | -3.8% |
| Q2 2021 | $3,256,000 | +199.5% | 15,337 | +155.7% | 0.03% | -36.6% |
| Q1 2021 | $1,087,000 | +50.1% | 5,997 | -7.7% | 0.04% | +51.9% |
| Q4 2020 | $724,000 | +3.3% | 6,497 | +0.4% | 0.03% | -10.0% |
| Q3 2020 | $701,000 | +35.9% | 6,474 | +4.6% | 0.03% | +25.0% |
| Q2 2020 | $516,000 | – | 6,191 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |